Novel amides of mycophenolic acid and some heterocyclic derivatives as immunosuppressive agents

J Enzyme Inhib Med Chem. 2022 Dec;37(1):2725-2741. doi: 10.1080/14756366.2022.2127701.

Abstract

The group of 18 new amide derivatives of mycophenolic acid (MPA) and selected heterocyclic amines was synthesised as potential immunosuppressive agents functioning as inosine-5'-monophosphate dehydrogenase (IMPDH) uncompetitive inhibitors. The synthesis of 14 of them employed uronium-type activating system (TBTU/HOBt/DIPEA) while 4 of them concerned phosphonic acid anhydride method (T3P/Py) facilitating amides to be obtained in moderate to excellent yields without the need of phenolic group protection. Most of optimised protocols did not require complicated reaction work-ups, including chromatographic, solvent-consuming methods. The biological activity assay was performed on the T-Jurkat cell line and peripheral mononuclear blood cells (PBMCs) which are both dedicated for antiproliferative activity determination. Each of designed derivatives was characterised by reduced cytotoxicity and benzoxazole analogue (A2) revealed the most promising activity. Subsequently, an observed structure-activity relationship was discussed.

Keywords: IMPDH inhibition; Mycophenolic acid; amide derivatives; benzoxazole; heterocycles.

MeSH terms

  • Amides / pharmacology
  • Amines
  • Anhydrides
  • Benzoxazoles
  • Enzyme Inhibitors / pharmacology
  • IMP Dehydrogenase
  • Immunosuppressive Agents* / chemistry
  • Inosine
  • Mycophenolic Acid* / chemistry
  • Solvents

Substances

  • Amides
  • Amines
  • Anhydrides
  • Benzoxazoles
  • Enzyme Inhibitors
  • Immunosuppressive Agents
  • Solvents
  • Inosine
  • IMP Dehydrogenase
  • Mycophenolic Acid

Grants and funding

Financial support for this work was supported by the internal grant DS035136 of Gdańsk University of Technology and statutory grant no. 02–10022/272 of Medical University of Gdańsk.